Although these results do not necessarily suggest that AKT3 expression directly contributes to or drives the instalment of the mesenchymal phenotype, they do indicate that high epithelial AKT3 gene expression can be used as a surrogate marker to identify carcinoma cells that have undergone EMT and/or adhere to a more mesenchymal phenotype. This evidence concerns the gene AKT3 and carcinoma.